Q2 2025 Holdings
Filed 2025-08-14 | 33 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $185.4M | 3,525,000 | 13.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $104.9M | 1,375,000 | 7.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $94.7M | 3,025,000 | 6.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $94.1M | 4,692,809 | 6.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $77.3M | 2,325,000 | 5.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $70.2M | 3,450,000 | 5.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $70.1M | 2,450,000 | 4.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $68.2M | 4,875,000 | 4.8% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $59.4M | 1,075,000 | 4.2% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $57.2M | 1,175,000 | 4.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $51.4M | 1,450,000 | 3.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $51.1M | 610,000 | 3.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $46.2M | 13,350,000 | 3.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $45.0M | 3,948,653 | 3.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $43.3M | 3,298,289 | 3.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $33.6M | 1,911,433 | 2.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $32.7M | 750,000 | 2.3% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $32.5M | 5,000,000 | 2.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $29.8M | 1,988,084 | 2.1% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $29.7M | 3,100,000 | 2.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $18.8M | 800,000 | 1.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $17.5M | 7,692,300 | 1.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $16.6M | 2,311,164 | 1.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $15.9M | 1,419,714 | 1.1% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $13.1M | 500,000 | 0.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $12.6M | 290,000 | 0.9% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $10.5M | 5,397,488 | 0.7% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $8.0M | 750,000 | 0.6% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $7.7M | 1,500,000 | 0.5% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $7.3M | 453,686 | 0.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $6.4M | 427,866 | 0.5% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $3.2M | 1,575,000 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $2.4M | 483,000 | 0.2% |